RADFORSK, The Norwegian Radium Hospital Research Foundation strategic research area (2023-2028) (Co-PI) TARACAN: Targeted Radionuclide Therapy for disseminated cancer
South-Eastern Norway Regional Health Authority/Norwegian Cancer Society (2020-2024) Theranostic radiopharmaceuticals for metastatic cancer
South-Eastern Norway Regional Health Authority (2019-2024) A novel PET-based prediction platform for myeloma patients
South-Eastern Norway Regional Health Authority and CarciNor (2018-24) Clinical usefulness of advanced image analysis of 18F-FDG PET/CT for in vivo characterisation of neuroendocrine carcinomas
Civitan, The Alzheimer Research Fund (2018-2023) Amyloid imaging by 18F-Flutemetamol PET/CT and MRI – clinical value and quantitative reference levels
Tulipan A, Gulati A, Haslerud T, Gray R, Biermann M(2024) Rebooting nuclear medicine specialist education under the COVID-19 pandemic: From plenary lectures to active e-learning Clin Physiol Funct Imaging(in press) DOI 10.1111/cpf.12875, PubMed 38413379
Galtung KF, Lauritzen PM, Rud E(2024) Reply to Fabio Zattoni, Fabrizio Dal Moro, Iliana Bednarova, and Giacomo Novara's Letter to the Editor re: Kristina F. Galtung, Peter M. Lauritzen, Gunnar Sandbæk, et al. Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison. Eur Urol Open Sci 2023;55:1-10 Eur Urol Open Sci, 61, 54-55 DOI 10.1016/j.euros.2024.01.014, PubMed 38357532
De Bortoli A, Nordøy I, Connelly JP, Viermyr HK, Bjerkreim RH, Broch K, Olsen PAS, Gude E, Fevang B, Jørgensen SF, Trøseid M, Steen T, Aukrust P, Andreassen AK, Skarpengland T(2024) Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort Int J Cardiol, 400, 131809 DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129